hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Medicenna Therapeutics Corp.
Will present two abstracts, both as oral presentations, at the Promise of Interleukin-2 Therapy Conference, taking place at the Centre International de Conférences Sorbonne Université in Paris, from September 4-7. Medicenna Therapeutics Corp. shares T.MDNA are trading down $0.01 at $2.15.
